Results 61 to 70 of about 29,631 (205)
Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2 [PDF]
Vaccines, 2021 It is not clear whether there is an association between adverse reactions and immune response after vaccination. Seven hundred and thirty-five vaccinees from our University Medical Center vaccination clinic provided information about sex, age and adverse reactions after first and second vaccination with BNT162b2. Adverse reactions were categorized into
Bauernfeind, Stilla +8 more
openaire +4 more sources
Risk of herpes zoster following mRNA COVID-19 vaccine administration
Expert Review of Vaccines, 2023 Background Adverse events following mRNA COVID-19 vaccines, including herpes zoster (HZ), have been reported. We conducted a cohort study to evaluate the association between mRNA COVID-19 vaccination and subsequent HZ at Kaiser Permanente Southern ...
Ana Florea +7 more
doaj +1 more source
, 2023 During COVID-19 vaccination campaign, possible ChAdOx1-S-associated risks of thrombosis with thrombocytopenia syndrome led to implement ChAdOx1-S/BNT162b2 heterologous vaccination, despite the limited information on its reactogenicity and safety.
Francesca Fortunato +13 more
core +1 more source
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization [PDF]
Nature, 2021 Abstract The emergence of the SARS-CoV-2 variant of concern Omicron (Pango lineage B.1.1.529), first identified in Botswana and South Africa, may compromise vaccine effectiveness and lead to re-infections 1 .
Sandile Cele +60 more
openaire +4 more sources
Vaccines, 2022 Analysis of longitudinal dynamics of humoral immune responses to the BNT162b2 COVID-19 vaccine might provide useful information to predict the effectiveness of BNT162b2 in preventing SARS-CoV-2 infection.
Atsuhiko Sakamoto +7 more
doaj +1 more source
Uptake of BNT162b2 vaccine in persons ≥80 years in Bavaria.
, 2021 Uptake of BNT162b2 vaccine in persons ≥80 years in Bavaria.
Andreas Beyerlein (328625) +7 more
core +1 more source
Journal of Korean Medical Science, 2023 Before the omicron era, health care workers were usually vaccinated with either the primary 2-dose ChAdOx1 nCoV-19 (Oxford-AstraZeneca) series plus a booster dose of BNT162b2 (Pfizer-BioNTech) (CCB group) or the primary 2-dose BNT162b2 series plus a booster dose of BNT162b2 (BBB group) in Korea.The two groups were compared using quantification of the ...
Seong-Ho Choi +6 more
openaire +2 more sources
Frontiers in Public Health, 2023 IntroductionSevere acute respiratory syndrome virus 2 (SARS-CoV-2) has caused over million deaths worldwide, with more than 61,000 deaths in Chile. The Chilean government has implemented a vaccination program against SARS-CoV-2, with over 17.7 million ...
Diego A. Díaz-Dinamarca +30 more
doaj +1 more source
in BNT162b2 vaccination against COVID-19 infection
, 2023 The global pandemic of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been developing all over the world for more than 3 years.
Johnny Chun-Chau Sung +25 more
core +1 more source
Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon [PDF]
, 2021 Facing new COVID-19 waves, the effectiveness of BBIBP-CorV has been noted to be low in countries whose populations were already administered two doses of the vaccine.
Bader, Mohammad +8 more
core +1 more source